-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B8Kq+VQis0qLpzll809LG3KvvZ7aElnsJn5+UD2st6EgJmBMFKwhpGYTmWl4OmxA 2G3z8nDRFs0JFq5TeS0KNA== 0000950123-09-009117.txt : 20090522 0000950123-09-009117.hdr.sgml : 20090522 20090519150328 ACCESSION NUMBER: 0000950123-09-009117 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090519 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20090519 DATE AS OF CHANGE: 20090519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HENRY SCHEIN INC CENTRAL INDEX KEY: 0001000228 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 113136595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1226 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-27078 FILM NUMBER: 09839350 BUSINESS ADDRESS: STREET 1: 135 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 6318435500 MAIL ADDRESS: STREET 1: 135 DURYEA RD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: SCHEIN HENRY INC DATE OF NAME CHANGE: 19950907 8-K 1 y77367e8vk.htm FORM 8-K 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 19, 2009
Henry Schein, Inc.
(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction
of incorporation) 		  0-27078
(Commission File Number) 		  11-3136595
(I.R.S. Employer
Identification No.)
     
135 Duryea Road, Melville, New York
(Address of principal executive offices) 		  11747
(Zip Code)
Registrant’s telephone number, including area code: (631) 843-5500
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
     On May 19, 2009, Dr. Margaret A. Hamburg voluntarily resigned from her position as a member of the Board of Directors of Henry Schein, Inc. (the “Company”) and withdrew her name as a nominee for re-election to the Company’s Board of Directors in connection with the Company’s forthcoming May 28, 2009 Annual Meeting of Stockholders (“2009 Annual Meeting”). Dr. Hamburg advised the Company that she has been confirmed as the Commissioner of the U.S. Food and Drug Administration and her responsibilities in that connection preclude her continued service as a member of the Company’s Board of Directors. The decision by Dr. Hamburg to resign from the Board of Directors was not the result of any disagreement with the Company.
     The Company has no current intention of naming another director to replace Dr. Hamburg as a current director or as a nominee for director in the upcoming election at the 2009 Annual Meeting.
SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  HENRY SCHEIN, INC.
(Registrant)
 		  
Date: May 19, 2009  By:   /s/ Michael S. Ettinger    
    Michael S. Ettinger   
    Senior Vice President and General Counsel   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----